AffaMed Therapeutics
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $170M
Investors
- 6
About AffaMed Therapeutics
Based in New York, US and founded in 2019, AffaMed Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital, and surgical products.
Who invested in AffaMed Therapeutics
6 investors across 1 round
See all investors in AffaMed Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 30, 2021
Amount
$170M
Investors
Questions about AffaMed Therapeutics
Who invested in AffaMed Therapeutics?
AffaMed Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AffaMed Therapeutics raised?
AffaMed Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AffaMed Therapeutics last raise money?
AffaMed Therapeutics's most recent round on record is a Series B, in Mar 2021.
What does AffaMed Therapeutics do?
Based in New York, US and founded in 2019, AffaMed Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital, and surgical products.
Where is AffaMed Therapeutics headquartered?
AffaMed Therapeutics is headquartered in New York, US.
Which VCs invest in companies like AffaMed Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AffaMed Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AffaMed Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.